Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Atorva 10 mg	229
Overall Study	STARTED	EZ/Simva 10 mg/20 mg	229
Overall Study	STARTED	Atorva 20mg	229
Overall Study	STARTED	EZ/Simva 10 mg/40 mg	228
Overall Study	STARTED	Atorva 40 mg	228
Overall Study	COMPLETED	Atorva 10 mg	220
Overall Study	COMPLETED	EZ/Simva 10 mg/20 mg	222
Overall Study	COMPLETED	Atorva 20mg	220
Overall Study	COMPLETED	EZ/Simva 10 mg/40 mg	216
Overall Study	COMPLETED	Atorva 40 mg	218
Overall Study	NOT COMPLETED	Atorva 10 mg	9
Overall Study	NOT COMPLETED	EZ/Simva 10 mg/20 mg	7
Overall Study	NOT COMPLETED	Atorva 20mg	9
Overall Study	NOT COMPLETED	EZ/Simva 10 mg/40 mg	12
Overall Study	NOT COMPLETED	Atorva 40 mg	10

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00409773/flow